| Medical and Health Sciences | Lifetime | 456 | FR 5 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 211 | FR 7 | 99.96 |
| Radiological and Ultrasound Technology | Lifetime | 2 | FR 1 | 99.89 |
| Pulmonary and Respiratory Medicine | Lifetime | 233 | FR 14 | 99.72 |
| Epidemiology | Lifetime | 295 | FR 11 | 99.62 |
| Critical Care and Intensive Care Medicine | Lifetime | 22 | FR 3 | 99.56 |
| Public, Environmental and Occupational Health | Lifetime | 740 | FR 11 | 98.95 |
| Infectious Diseases | Lifetime | 338 | FR 22 | 98.78 |
| Oncology | Lifetime | 777 | FR 31 | 98.37 |
| Emergency Medicine | Lifetime | 747 | FR 19 | 92.03 |
| Hematology | Lifetime | 914 | FR 41 | 90.51 |
| Nephrology | Lifetime | 818 | FR 27 | 87.01 |
| Radiological and Ultrasound Technology | 2021-2025 | 11 | FR 1 | 98.88 |
| Epidemiology | 2021-2025 | 261 | FR 10 | 97.94 |
| Infectious Diseases | 2021-2025 | 161 | FR 5 | 97.25 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 309 | FR 23 | 97.13 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 56 | FR 6 | 95.38 |
| Oncology | 2021-2025 | 659 | FR 35 | 90.12 |
| Immunology | 2021-2025 | 592 | FR 22 | 83.04 |
| Family and Patient Care in Intensive Care Units | Lifetime | 1 | FR 1 | 99.97 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 9 | FR 1 | 99.90 |
| Neutropenia and Cancer Infections | Lifetime | 5 | FR 1 | 99.88 |
| Palliative Care and End-of-Life Issues | Lifetime | 13 | FR 1 | 99.83 |
| Long-Term Effects of COVID-19 | Lifetime | 26 | FR 2 | 99.44 |
| Sepsis Diagnosis and Treatment | Lifetime | 21 | FR 2 | 99.83 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 21 | FR 2 | 99.73 |
| Respiratory Support and Mechanisms | Lifetime | 39 | FR 3 | 99.83 |
| Nosocomial Infections in ICU | Lifetime | 18 | FR 5 | 99.74 |
| COVID-19 Clinical Research Studies | Lifetime | 234 | FR 10 | 98.88 |
| Pleural and Pulmonary Diseases | Lifetime | 85 | FR 3 | 98.97 |
| Healthcare Decision-Making and Restraints | Lifetime | 42 | FR 1 | 98.49 |
| Antifungal resistance and susceptibility | Lifetime | 178 | FR 13 | 98.90 |
| Complement system in diseases | Lifetime | 115 | FR 8 | 98.49 |
| Pneumonia and Respiratory Infections | Lifetime | 312 | FR 14 | 98.87 |
| Healthcare professionals’ stress and burnout | Lifetime | 242 | FR 1 | 97.19 |
| COVID-19 and healthcare impacts | Lifetime | 646 | FR 16 | 93.66 |
| Hematological disorders and diagnostics | Lifetime | 341 | FR 10 | 95.37 |
| Renal Diseases and Glomerulopathies | Lifetime | 713 | FR 50 | 96.89 |
| Emergency and Acute Care Studies | Lifetime | 955 | FR 9 | 95.74 |
| Grief, Bereavement, and Mental Health | Lifetime | 440 | FR 3 | 95.52 |
| Fungal Infections and Studies | Lifetime | 746 | FR 37 | 95.74 |
| Blood disorders and treatments | Lifetime | 514 | FR 31 | 94.60 |
| Acute Kidney Injury Research | Lifetime | 706 | FR 22 | 94.02 |
| Neurological Complications and Syndromes | Lifetime | 837 | FR 38 | 88.89 |
| Patient Dignity and Privacy | Lifetime | 715 | FR 1 | 89.59 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 232 | FR 8 | 86.33 |
| Family and Patient Care in Intensive Care Units | 2021-2025 | 1 | FR 1 | 99.90 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 2 | FR 1 | 99.24 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 14 | FR 1 | 99.52 |
| Long-Term Effects of COVID-19 | 2021-2025 | 82 | FR 3 | 98.84 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 39 | FR 1 | 98.81 |
| Respiratory Support and Mechanisms | 2021-2025 | 61 | FR 9 | 99.18 |
| Neutropenia and Cancer Infections | 2021-2025 | 34 | FR 5 | 96.99 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 181 | FR 17 | 96.88 |
| Nosocomial Infections in ICU | 2021-2025 | 59 | FR 13 | 95.38 |
| Healthcare professionals’ stress and burnout | 2021-2025 | 151 | FR 4 | 95.06 |
| Complement system in diseases | 2021-2025 | 73 | FR 6 | 95.66 |
| Antifungal resistance and susceptibility | 2021-2025 | 228 | FR 13 | 95.18 |
| Pneumonia and Respiratory Infections | 2021-2025 | 745 | FR 38 | 88.55 |
| Fungal Infections and Studies | 2021-2025 | 403 | FR 24 | 90.01 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 638 | FR 31 | 82.08 |
| Grief, Bereavement, and Mental Health | 2021-2025 | 624 | FR 5 | 77.33 |
| Neurological Complications and Syndromes | 2021-2025 | 404 | FR 24 | 66.82 |